Literature DB >> 8159002

Growth pattern and prognosis of gastric cancer invading the subserosa.

Y Maehara1, T Oshiro, Y Adachi, S Ohno, K Akazawa, K Sugimachi.   

Abstract

Gastric cancer invading the subserosa with infiltrative growth was classified as part of the serosal invasion group and named prognostic serosal invasion positive [ps(+)] histologically. We analyzed clinicopathological features and prognosis of 166 Japanese patients with gastric cancer invading the subserosa, according to the growth pattern. All patients were treated in the Department of Surgery II, Kyushu University. Patients with infiltrative growth (ss gamma) were younger and their tumors were frequently undifferentiated compared to findings in those with noninfiltrative growth: expansive (ss alpha) and intermediate growth (ss beta). There was no difference in any other clinicopathological characteristic between those with infiltrative and noninfiltrative growth tumors. The 10-year survival rate was 66.7% for the infiltrative type and 54.2% for the noninfiltrative type, with no statistically significant difference. Lymph node metastasis, curative resection, and extended lymph node dissection, but not growth pattern, proved to be independent prognostic factors, as determined by multivariate analysis. Our findings suggest that it is not the growth pattern which affects the prognosis of ss cancers. Extensive lymph node dissection should be done when lymph node metastasis is present.

Entities:  

Mesh:

Year:  1994        PMID: 8159002     DOI: 10.1002/jso.2930550402

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  7 in total

1.  Prognostic implication of infiltrative growth pattern and establishment of novel risk stratification model for survival in patients with upper urinary tract urothelial carcinoma.

Authors:  Takeshi Hashimoto; Jun Nakashima; Rie Inoue; Tatsuo Gondo; Yoshio Ohno; Masaaki Tachibana
Journal:  Int J Clin Oncol       Date:  2013-04-03       Impact factor: 3.402

2.  Lymphatic invasion is a significant indicator of poor patient prognosis in lung squamous cell carcinoma.

Authors:  Ryota Masuda; Hiroshi Kijima; Madoka Nito; Atsushi Wada; Tomohiko Matsuzaki; Yoichiro Ikoma; Kenei Nakazato; Daisuke Masuda; Makiko Tanaka; Hiroyuki Kobayashi; Sadaki Inokuchi; Masayuki Iwazaki
Journal:  Mol Med Rep       Date:  2017-02-28       Impact factor: 2.952

3.  Pathological tumor infiltrative pattern and sites of initial recurrence in stage II/III gastric cancer: Propensity score matching analysis of a multi-institutional dataset.

Authors:  Nobuhiko Nakagawa; Mitsuro Kanda; Seiji Ito; Yoshinari Mochizuki; Hitoshi Teramoto; Kiyoshi Ishigure; Toshifumi Murai; Takahiro Asada; Akiharu Ishiyama; Hidenobu Matsushita; Chie Tanaka; Daisuke Kobayashi; Michitaka Fujiwara; Kenta Murotani; Yasuhiro Kodera
Journal:  Cancer Med       Date:  2018-11-08       Impact factor: 4.452

4.  Prognostic significance of serum inflammation indices for different tumor infiltrative pattern types of gastric cancer.

Authors:  Yu-Fei Wang; Xin Yin; Tian-Yi Fang; Yi-Min Wang; Lei Zhang; Xing-Hai Zhang; Dao-Xu Zhang; Yao Zhang; Xi-Bo Wang; Hao Wang; Ying-Wei Xue
Journal:  World J Gastrointest Oncol       Date:  2022-04-15

5.  Tumor budding is a significant indicator of a poor prognosis in lung squamous cell carcinoma patients.

Authors:  Ryota Masuda; Hiroshi Kijima; Naoko Imamura; Naohiro Aruga; Yusuke Nakamura; Daisuke Masuda; Haruka Takeichi; Nobusuke Kato; Tomoki Nakagawa; Makiko Tanaka; Sadaki Inokuchi; Masayuki Iwazaki
Journal:  Mol Med Rep       Date:  2012-08-27       Impact factor: 2.952

6.  Factors associated with peritoneal metastasis in non-serosa-invasive gastric cancer: a retrospective study of a prospectively-collected database.

Authors:  Baojun Huang; Zhe Sun; Zhenning Wang; Chong Lu; Chengzhong Xing; Bo Zhao; Huimian Xu
Journal:  BMC Cancer       Date:  2013-02-04       Impact factor: 4.430

7.  Ki-67 labeling index affects tumor infiltration patterns of lung squamous cell carcinoma.

Authors:  Daisuke Masuda; Ryota Masuda; Tomohiko Matsuzaki; Naoko Imamura; Naohiro Aruga; Makiko Tanaka; Sadaki Inokuchi; Hiroshi Kijima; Masayuki Iwazaki
Journal:  Mol Med Rep       Date:  2015-09-24       Impact factor: 2.952

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.